Displaying 51–75 of 270 results for Paul Thomas, Senior Editor
Makers of drugs for lethal injection face pressure to spurn U.S. prisons.
Probabilistic rather than deterministic modeling is essential, says Quintiles Davis Walp.
Middle managers in pharma today have a tough, thankless jobbut someones got to do it, and many do it well.
Organizations with built-in risk management frameworks allow middle managers to thrive, says Scott Chizzo, Maxiom Groups president and chief consultant, in this exclusive interview.
Pharma's middle managers carry on despite a "damned if we do, damned if we don't" environment.
Mike Ponstingl, owner of Custom Sensors & Technology, shares insight into new methods of monitoring fermentation and other bioprocesses.
People generally dont resist change, says the Life Cycle Institute's Bill Wilder. They resist being changed when they don't know why.
A Milwaukee newspaper reminds an industry of its flaws.
Industry consultant Jane Chin examines what makes the jobs of pharmas middle managers so tough, and how they can succeed against the odds.
In this interview, Wessels talks with PharmaManufacturing.com Senior Editor Paul Thomas about why sustainability matters, and how sustainable practices can become part of a drug manufacturers genetic makeup.
A new survey sheds light upon choices and challenges.
June 2011 Issue of Pharmaceutical Manufacturing
As pharma and biopharma companies deal with turbulent times, they look to a more sophisticated (and even real-time) secondary market to help manage equipment and assets. An industry expert surveys the scene, and provides smart shopping and selling advice, software
Reports of the demise of radio frequency identification as a breakthrough supply chain technology have been greatly exaggerated.
Recent research suggests not, and prompts FDA to clarify its position on the issue.
Steris Finn-Aqua has developed a new technology for the automatic decontamination of pharma/biopharma effluent.
At PDA 2011, at issue was whether current EMA guidelines are rational or risky; also, a look at new filtration products on the market.
Smart phones and similar devices are pushing the wireless envelope, but wireless process control still faces traditional hurdles.
Elan's head of manufacturing, Kevin Brady, talks about what works, and why.
With FDA and the Obama administration on alert, it is drug manufacturers' turn to address a crisis.
A summary of Pfizer's Martin Guinn talk from the DynoChem 2011 user group.
A summary of Lilly's Shankar Vaidyaraman's talk from the DynoChem 2011 user group.
A summary of Lilly's Shekhar Viswanath talk from the DynoChem 2011 user group.
Know when youre on shaky ground, and then respond promptly and thoroughly to FDAs requests, says J&J Janssens Patti Gupta.
If it cant be measured, it cant be green; leading manufacturers are turning to advanced metrics to show just how sustainable their products, processes, and plants really are.